Group cognitive analytic therapy for female survivors of childhood sexual abuse by Calvert, R. et al.
This is an author produced version of Group cognitive analytic therapy for female survivors
of childhood sexual abuse.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/102719/
Article:
Calvert, R., Kellett, S. and Hagan, T. (2015) Group cognitive analytic therapy for female 
survivors of childhood sexual abuse. British Journal of Clinical Psychology, 54 (4). pp. 
391-413. ISSN 0144-6657 
https://doi.org/10.1111/bjc.12085
This is the peer reviewed version of the following article: Calvert, R., Kellett, S. and Hagan,
T. (2015), Group cognitive analytic therapy for female survivors of childhood sexual abuse.
Br J Clin Psychol, 54: 391–413, which has been published in final form at 
doi:10.1111/bjc.12085. This article may be used for non-commercial purposes in 
accordance with Wiley Terms and Conditions for Self-Archiving.
promoting access to
White Rose research papers
eprints@whiterose.ac.uk
http://eprints.whiterose.ac.uk/
 1 
Objectives. The effectiveness of Cognitive Analytic Therapy delivered in groups 
has been under researched considering the popularity of the approach.  This study 
sought to investigate the effectiveness of 24-sessions of group Cognitive Analytic 
Therapy (GCAT) delivered in routine practice for female survivors of childhood 
sexual abuse (CSA).  Methods.  In a longitudinal cohort design, N=157 patients 
were treated with 24-sessions of GCAT.  Validated outcome measures were 
administered at assessment, pre and post-GCAT.  This enabled rates of reliable and 
clinically significant change to be compared between wait-time and active group 
treatment.  The uncontrolled treatment effect size was then benchmarked against 
outcomes from matched studies.  Results. On the primary outcome measure, GCAT 
facilitated a moderate effect size of 0.34 with 11% of patients completing 
treatment meetin Ǯǯ Ǥ  -out rate was 19%.  Significant 
improvements in interpersonal functioning, anxiety and wellbeing occurred during 
GCAT in comparison to wait-time on secondary outcome measures.  Conclusions. 
GCAT appears a promising intervention for adult female CSA survivors, with 
further controlled evaluation indicated.   
 
Practitioner points. 
o GCAT appears a promising and acceptable intervention for female CSA 
survivors with high levels of psychological distress. 
o Long-term follow up studies are required with CSA survivors to index the 
clinical durability of GCAT.  
o A GCAT treatment fidelity measure needs to be developed and evaluated. 
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A cross-cultural meta-analysis found that up to 20% of women and 8% of men 
report being sexually abused before the age of 18 (Pereda, Guilera, Forns, & 
Gomez-Benito, 2009).  In the UK, similar rates are reported with 21% of females 
and 11% of males disclosing histories of childhood sexual abuse (CSA; Cawson, 
Wattam, Brooker, & Kelly, 2000).  There are, however, acknowledged clinical and Ǯǯ rates 
of CSA.  For example, varying definitions of CSA and the wide range of data 
collection techniques employed produce often widely differing prevalence rates 
(Putnam, 2003).  Although 'survivors' constitute a heterogeneous clinical 
population with diverse trauma experiences and subsequent outcomes (Rutter, 
2007), it is generally agreed that CSA appears to be a psychologically toxic early 
experience; Manglio (2009) studied 270,000 subjects from 587 studies to evidence 
that CSA survivors were at significant risk of a wide range of medical, 
psychological, behavioural and sexual disorders.   
Whilst a variety of models have been proposed to understand the 
heterogeneous and often extensive and pervasive negative impact of CSA (see 
Freeman & Morris, 2001, for a review), there is yet no widely supported 
conceptualisation to guide treatment (Llewelyn, 2002) and a paucity of knowledge 
regarding effective interventions (for reviews see Llewelyn, 1997; Martsolf & 
Draucker, 2005; Price, Hilsenroth, Petretic-Jackson, & Bonge, 2001; Taylor & 
Harvey, 2010).  There is therefore a need develop a robust and relevant evidence-ǯ
(Westbury & Tutty, 1999).  However, there are many complex challenges in 
conducting outcome research for CSA, including multiple treatment targets (Trask, 
Walsh & DiLillo, 2011), the interaction of often co-occurring trauma experiences 
(including sexual, physical, emotional abuse and neglect; Briere & Runtz, 1990), 
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the diverse context of abuse experiences and disclosure (Ramchandani & Jones, 
2003) and the lack of an agreed definition of CSA (Peters, Wyatt & Finkelhor, 
1986).  This study was conducted in routine practice and the service used the 
following definition provided by the World Health Organisation (1999): ǲ
sexual abuse is the involvement of a child in sexual activity that he or she does not 
fully comprehend, is unable to give informed consent to, or for which the child is 
not developmentally prepared and cannot give consent, or that violate the laws or 
social taboos of society. Child sexual abuse is evidenced by this activity between a 
child and an adult or another child who by age or development is in a relationship 
of responsibility, trust or power, the activity being intended to gratify or satisfy the 
needs Ǥǳ  
 In terms of treatment of the difficulties arising from CSA, there is a tension 
between controlled efficacy studies (which prioritise higher degrees of internal 
validity through rigorously controlled methods) and effectiveness studies 
completed in routine practice settings (which tend to exemplify high external 
validity due to being conducted in real-world settings; Roth & Fonagy, 2005).  The 
clinical utility of controlled trials has been challenged (Cartwright, 2007), due to 
use of strict inclusion/exclusion criteria leading to difficulties in applying results to 
routine practice.  A practice-based evidence (PBE) paradigm has therefore been 
advocated (Cahill, Barkham & Stiles, 201 ?ȌǮǯ(Holloway, 2002) to usefully complement and contextualise 
efficacy evidence (Bower & Gilbody, 2010).  Effectiveness and efficacy of treatment 
is often summarised in terms of an effect size of the intervention, which is a ȋǤǤǯ
and odds ratios). The acceptability of a treatment is also an important component 
of its effectiveness (Cavanagh et al., 2009).  For example, meta-analytic evidence 
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suggests that dropout rates from therapy are particularly high for survivors of CSA 
(Taylor & Harvey, 2010).  So the manner in which a therapy engages and retains 
CSA survivors in treatment is also an important index of its usefulness (DoH, 
2007).   
Several studies (e.g., Alexander, Neimeyer, Follette, Moore, & Harter, 1989; 
Hazzard, Rogers, & Angert, 1993) and reviews (Kessler, White, & Nelson, 2003; 
Taylor & Harvey, 2010) highlight the promise of group psychotherapy for CSA 
survivors.  Whilst group cognitive analytic therapy (GCAT) has been advocated as a 
treatment method (Hagan & Gregory, 2001), the associated evidence base is small 
and contains just three small evaluations of routine practice, with insufficient 
reporting of results to compute effect sizes.  Duignan and Mitzman (1994) 
delivered a 12-week GCAT intervention to seven survivors and found significant 
improvements in depression and wellbeing, although selection bias may have 
influenced results.  Clarke and Llewelynǯ (1994) study of seven female survivors 
showed that despite positive ǡǯ
constructs changed suggesting the persistence of the centrality of abuse despite 
the GCAT intervention.  Finally, Ryan, Nitsun, Gilbert and Mason (2005) completed 
a CAT-informed psycho-educational group with 22 survivors and found 
statistically and clinically significant improvements to general wellbeing.  All the 
GCAT studies had high external validity due to being conducted in routine practice, 
but suffered from small sample sizes and poor internal validity (e.g. lack of 
diagnostic validity, absence of treatment fidelity measurement and no 
comparison/control groups). 
 In summary, a wealth of evidence confirms the negative, long-term 
psychological impact of CSA and yet relevant outcome research remains in its 
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empirical infancy.  GCAT is a treatment approach currently unsupported by a 
robust evidence base, despite the recent call to produce evidence for group CAT 
delivery (Ryle, Kellett, Hepple & Calvert, 2014).  This study aimed to evaluate the 
outcomes of GCAT in routine clinical practice for female CSA survivors, through 
investigating differences between outcomes during treatment versus wait-time.  
This method supports inferences that any differences found would be attributable 
to introduction of treatment (Cisler, Barnes, Farnsworth, & Sifers, 2007).  This 
study also employed benchmarking (Lueger & Barkham, 2010) to contextualise the 
effect size of GCAT against other group psychotherapy outcome studies for female 
CSA survivors.  The study hypothesised that (1) significant improvements in 
distress and functioning would occur during GCAT, (2) more patients would 
recover during GCAT than during wait-time and (3) outcomes for GCAT would be 
equivalent to those found in published studies of group treatments in female 
survivor populations.   
Method 
Setting and design 
Ethical approval was granted by the appropriate UK NHS Research Ethics ǯ

department.  The study used a longitudinal, cohort design.  GCAT was delivered in 
a tertiary psychotherapy service, which offered GCAT (and other individual 
therapies) to adult survivors of CSA referred from Secondary Care.  Consequently 
all patients had complex care packages that included concurrent input from other 
aspects of mental health services (e.g. psychiatric out-patient appointments, day 
care services and on-going contact with care co-ordinators). As no strict 
inclusion/exclusion criterion was applied, the patients were clinically 
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representative (Shadish, Matt, Navarro, Siegle, Crit-Christoph, & Hazelrigg et al., 
1997). 
 
Sample and Procedure 
Patients receiving GCAT all had histories of CSA and were referred to the service 
on the criteria that the CSA played a central role in their ongoing psychological 
distress, disorganised engagement patterns with services, elevated risk and/or 
poor self-care. The service responded to appropriate referrals by sending a letter 
to the patient inviting them to an assessment appointment.  Included with the 
letter was a booklet containing a range of outcome measures and a request for it to 
be returned to the service prior to the assessment.  Initial face-to-face assessment 
appointments were conducted by a GCAT facilitator and typically lasted for 
approximately 60 minutes.  No standardised diagnostic instruments were used 
during the assessment.  Patients were not randomly allocated to interventions, but 
involved in collaborative discussions concerning possible treatment options. A 
variety of treatment choices were negotiated, with GCAT being one treatment 
option. Allocation thus reflected clinical decision-making rather than adherence to 
randomisation procedures (Buckley, Newman, Kellett & Beail, 2006). Participants 
who opted-in to GCAT were invited to join the next group and placed on a waiting 
list.  At this point patients were provided with tailored CSA psychoeducational 
resource materials to enable them to prepare for GCAT (e.g. Ainscough & Toon, 
2000).  The time interval between assessment and start of the next group (pre-
GCAT) represented a naturally occurring waitlist control, although this time varied 
according to staff availability, as only one GCAT group ran at any one time.  Wait-
times were a maximum of eight months.   
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For the purposes of the study, a clinician retrospectively coded information 
concerning the psychological difficulties reported at clinical assessment.  
Information was coded according to presence of internalising difficulties (e.g. 
depression/anxiety) and externalising difficulties (e.g. aggression), current 
substance use, self-harm behaviours, sexual difficulties (conceptualised as either 
an aversion or preoccupation with sexual activity) and re-victimisation 
experiences (e.g. domestic violence). No information was available regarding 
patients' CSA experiences (e.g. perpetrator(s), severity, type or duration of abuse, 
age at onset, etc.), as participants were never required to disclose the details of 
their abuse histories during the assessment.    
This study drew on a clinical database of all patients referred to the service 
(N=378) from which a subset of those who had been offered GCAT (N=157) were 
identified, using the following post-hoc criteria; (1) patients had completed 
assessment measures, (2) attended assessment and (3) been offered and accepted 
GCAT regardless of whether or how much of GCAT they subsequently attended.  
This therefore identified an initial sample of patients who had been offered GCAT 
(N=157), from which a further sub-group went on to complete GCAT treatment; 
the Ǯǯȋ ? ? ? ?Ǣ	 ?
the study).     
 
insert figure 1 here please 
 
Outcome measures were completed at three time points (assessment, pre 
and post-GCAT) by 57% (N=89) of those patients offered GCAT (N=157). For 
participants not completing outcomes following assessment (i.e. did not complete 
pre-GCAT measures N=47; did not complete post-GCAT measures, N=21), last 
 8 
observation carried forward was employed (Montori & Guyutt, 2001; Barkham et ǡ ? ? ? ?ȌǤǮǯ
conservative estimate of change (i.e. this sub-sample would show no change 
during GCAT).   
The age of patients who were offered GCAT (N=157) ranged from 18 to 64 ȋ ? ? ?ǡ ? ? ?Ȍǡ ? ? ?Ǯǯǡ
55% reported currently being in a relationship and 28% in paid employment.  
Difficulties with current substance use were recorded in 11% of clinical notes of 
those offered GCAT at assessment. Self-harming behaviour was recorded in 31% of 
assessment records and 10% noted current sexual difficulties. Furthermore, at 
assessment, 94% of the clinical assessments recorded internalising difficulties (i.e. 
depression, anxiety) and 29% reported current externalising difficulties (i.e. 
aggression). Experiences of re-victimisation were recorded in 12% of cases. 
 
Analysis strategy  
Overall the main analyses comprised of repeated measures ANOVAs of wait-time 
versus active treatment, calculation of rates of reliable and clinically significant 
change, computation of uncontrolled effect sizes and benchmarking the effect size 
on the primary outcome measure with the extant evidence.  
Change during wait-list and GCAT was evaluated using 2 (completers/non-
completers) x 3 (assessment/pre-GCAT/post-GCAT) ANOVAS.  The reliable change 
index (RCI; Jacobson & Truax, 1991) was used to evaluate the extent to which any ǯ
nd measurement 
error, and so defined reliable change. Clinically significant change required 
participants' scores on a measure pre/post GCAT to shift from within to outwith 
the scores associated with a clinical population.  Where normative data was not 
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available, clinically significant change was operationalised by either (a) change in 
scores by at least two standard deviations from the mean of a clinical population 
towards a non-clinical population, or (b) change to within two standard deviations 
of the mean of a non-clinical population.   This study used the more stringent index 
of clinically significant change using the published test-retest co-efficient and 
published clinical thresholds representing the cut-off between clinical and 
community populations where available.  However, where these were not 
available, a clinical cut-off was derived (see Table 1 for a summary of indices and 
evidence used to calculate the individual change rates).  Combining both individual 
change indices enabled rates of reliable and clinically significant change (RCSC) to 
be calculated.  RCSC is often used as an index of recovery in practice-based 
evidence (Barkham, Stiles, Connell & Mellor-Clark, 2012). McNemar tests were 
used to compare recovery rates between (1) assessment to start of GCAT, and (2) 
pre-post GCAT.  ȋǯd+), that is the amount of change within 
GCAT from start to end of group without reference to a control/alternative 
treatment condition, were calculated using the pre-post change score during group 
therapy divided by the pre-group standard deviation (Barkham, Gilbert, Connell, 
Marshall, & Twigg, 2005; Westbrook & Kirk, 2005).  There are no agreed 
conventions for classifying within-group effect sizes, however, it is reasonable to 
assume that within-group effect sizes would be larger than between-group effect 
sizes. Also given the severe, enduring and complex difficulties of the sample, effect 
sizes would be expected to be smaller than those achieved in other clinical 
populations. To reflect these issues, the Conway, Audin, Barkham, Mellor-Clark, & 
Russell (2003) effect size approach was followed for group-based work with 
clients with severe/complex difficulties.  This classifies a within-group 
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uncontrolled effect size of d+  ? 0.2 as 'moderate improvement' and d+  ? 0.5 as 
'marked improvement'. This study benchmarked the GCAT effect size on the 
primary outcome measure against other group therapies for female survivors of 
CSA that have used the Brief Symptom Inventory (Derogatis & Melisaratos, 1983) 
or its predecessor the Symptom Checklist-90-Revised (SCL-90-R; Derogatis, 
Lipman, & Covi, 1973). The results of which were summarised in a forest plot.   
 
Measures 
Patients completed a battery of outcome measures at three time points; 
assessment, pre-GCAT in the first GCAT session and post-GCAT at the final session. 
If patients provided insufficient outcome data on a measure at any time-point 
(according to the scoring procedure for each measure), no score was calculated for 
that measure.  
 
Primary Measure 
Brief Symptom Inventory (BSI; Derogatis & Melisaratos, 1983) 
The BSI is a well validated and reliable short version of the SCL-R-90 (Derogatis, 
Lipman, & Covi, 1973).  The 53-item scale measures psychiatric symptoms across 
nine primary symptom dimensions and three global indices: Global Severity Index 
(BSI-GSI), Positive Symptom Total (PST) and Positive Symptom Distress Index 
(PSDI).   Current D = 0.97.  The BSI-GSI is a mean score, combining information 
about the overall number and intensity of distressing symptoms. The clinical Ǯǯ
-score of 63 or higher (Derogatis, 1993), which 
equates with a threshold score of 0.78. The Brief Symptom Inventory (BSI) was 
selected as the primary outcome measure because, (a) it is a valid and reliable 
index of psychological distress (Derogatis & Melisaratos, 1983), (b) given the 
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diverse nature of difficulties that survivors experience, a symptom specific ǯȋȌ it has 
been the most widely used measure across the CSA group outcome evidence base.   
 
Secondary measures 
Inventory of Interpersonal Problems-32 (IIP-32; Barkham, Hardy, & Startup, 1996).  
This measure is used to identify interpersonal difficulties and is a valid and reliable 
short version of the original 127-item scale (Horowitz et al., 1988).  The IIP-32 has 
eight subscales forming four bipolar factors: hard to be assertive vs. too 
aggressive; hard to be sociable vs. too open; hard to be supportive vs. too caring 
and hard to be involved vs. too dependent. Current D = 0.87.  Given that there are 
no published clinical thresholds for the IIP-32, a cut-off score of 1.39 was derived 
according to Jacobson and Truax's (1991) criterion 'C' (i.e. utilising normative data 
reported in Barkham et al. (1996) to enable rates of clinically significant change to 
be calculated). 
Rosenberg Self-Esteem Scale (RSES; Rosenberg, 1989) 
The RSES is a ten item scale used to measure perceptions of global self-worth 
(Rosenberg, 1989).   Silber and Tippett (1965) reported a test-retest co-efficient of 
0.85, and Liem and Boudewyn (1999) an internal consistency co-efficient of 0.88 
with survivors of CSA.  Current study D = 0.81.  A clinical threshold of 25.22 was 
determined as two standard deviations above the assigned-to-
ǯ
mean score at assessment to enable rates of clinically significant change to be 
calculated (Evans, et al., 1998). 
Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983) 
The HADS is a valid and reliable 14-item measure (Savard, Laberge, Gauthier, 
Ivers, & Bergeron, 1998) of anxiety (HAD-A) and depression (HAD-D).  Crawford, 
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Henry, Crombie, and Taylor (2001) suggest a clinical threshold value of 11.  
Current study D = 0.83 for both HADS-A and HAD-D.   
General Health Questionnaire-28 (GHQ-28; Goldberg & Hillier, 1979).  
The GHQ-28 is a valid and reliable measure of non-psychotic mental health 
difficulties yielding a total score, and four sub-scales: somatic symptoms, 
anxiety/insomnia, social dysfunction and severe depression. There are two scoring 
methods for the GHQ-28; Likert scoring and GHQ scaled scores, with the latter 
employed in the current study.  A WHO study of 5,438 participants from 15 
different locations, derived a clinical threshold of more than or equal to seven 
(Goldberg et al., 1997).  Current study D = 0.95.   
 
insert table 1 here please 
 
Facilitators 
There were 14 female GCAT facilitators; seven clinical psychologists (two of whom 
were CAT accredited practitioners), two mental health nurses and five trainee 
clinical psychologists with prior experience of delivery of individual CAT.  Two 
staff members co-facilitated each group session and trainee psychologists were 
always paired with qualified clinical psychologists when delivering groups. The 
ACAT accredited practitioners supervised all facilitators.  
 
Intervention: Group Cognitive Analytic Therapy  
CAT integrates psychoanalytic and cognitive models to offer a transdiagnostic, 
time-limited (usually 16 or 24 sessions) and relational approach to facilitating 
therapeutic change (Ryle & Kerr, 2002).  The evidence-base for CAT is made up of 
generally high quality studies (Calvert & Kellett, 2014), with a weighted mean 
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effect size across CAT outcome studies of d+ = 0.83 (Ryle, Kellett, Hepple & Calvert, 
2014).  Theoretically, CAT draws on personal construct theory (Kelly, 1956) and 
object relations theory (Ryle, 1985), asserting that mental representations of self, 
others and the world are developmentally formed by early interactions with 
significant others (Ryle & Kerr, 2002). These internalised, early object relations are Ǯǯ and influence how individuals anticipate and react to 
relationships. CAT suggests that CSA survivors have learnt a repertoire of Ǯtarget problem proceduresǯ(TPPs; commonly referred to as 
traps, snags and dǢƬǡ ? ? ? ?ȌǮǯ
experienced in childhood (Clarke & Llewelyn, 1994), but which are now 
maladaptive as an adult. Change in CAT is considered to arise from the process of ǡǮǯ that develops a shared understanding 
to explain the developmental origins of difficulties (Ryle, 1995). A sequential 
diagrammatic reformulation (SDR) is constructed to identify predominant 
reciprocal roles and repetitive patterns that maintain difficulties and limit change 
(Ryle, 1997). The SDR is used to facilitate recognition of damaging patterns, both 
external to therapy and within the therapeutic relationship.  Ǯǯ
actively revise maladaptive procedures, with the therapist aiming to offer a 
containing, non-collusive experience throughout.  
Broadly, the structure of GCAT followed a reformulation, recognition and 
revision approach (Hagan & Gregory, 2001). Groups ran for 24 weekly sessions 
with each session lasting 90 minutes.  Group size varied according to referral rate, 
with a median of eight patients in each group.  Group members completed the Ǯ	ǯǢ-assessment questionnaire 
that helps patients to initially recognise their traps, snags and dilemmas and also 
various self-states (e.g. dissociated 'zombie' states).  Facilitators delivering GCAT 
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used a resource file that defined the outlines and aims for each group session.  
However, GCAT was not manualised and specific interventions within groups 
varied over time and in response to the needs of the members and group 
dynamics.  
Individual diagrammatic reformulations were developed with group 
members (Duignan & Mitzman, 1994), alongside a group reformulation based ǢǮǯ
(Hagan & Gregory, 2001).  Stowell-Smith, Gopfert and Mitzman (2001) noted that ǲǳduring group dynamics, with group 
diagrammatic reformulations providing a framework for reflection and change.  
Recognition during GCAT was facilitated via patient self-monitoring (e.g. 
completing diaries to increase awareness and enourage reflection on TPPs) and 
reflecting on any enactments within the group setting (e.g. looking after the needs 
of other group members as a means of neglecting oneself).  In the third phase of Ǯǯǡexits were identified within groups to actively revise the maladaptive 
patterns (e.g. finding ways to safely expressing anger, setting interpersonal 
boundaries, and improving self-care).  GCAT utilised a judicious approach to 
scaffolding 'exits' in response to the needs of group members.  Exits drew on a 
range of change methods (Ryle, 1995) and were practiced between sessions via 
scheduled homework.  The time-limited nature of GCAT meant that emphasis was 
also placed on the importance of therapeutic endings.  Therefore at termination, 
GCAT members and facilitators exchanged goodbye letters, enabling reflection on 
changes achieved, potential future goals and obstacles to change.   
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Results 
Study Group Comparisons  
Table 2 contains the demographic details for patients offered GCAT (N=157) and 
all other patients who were referred to the service but not offered GCAT (N=211). 
Patients offered GCAT were more likely to be in a relationship (ɖ2 (1, N=325) =6.88, 
p=0.009). There were no other significant differences regarding age, ethnicity or 
employment status.  Table 3 contains the outcome scores at assessment for 
patients offered GCAT (N=157) and patients who returned intake questionnaires 
but were not offered GCAT (N=81). Patients offered GCAT had significantly lower 
self-esteem scores (Z=-5.34, n1=71, n2=149, p<0.001). GCAT patientsǯ 
on the primary outcome measure at assessment (BSI-GSI; M=2.28, SD=0.87), was 
higher than UK outpatient norms (M=1.66, SD = 0.83; Ryan, 2007) and previous 
GCAT participants (M=1.80, SD=1.13; Clarke & Llewelyn, 1994; see Table 1). One 
hundred and forty patients (91%) of the GCAT sample scored within a clinical 
range on the BSI at assessment.   
 
insert table 2 and 3 here please 
 
Acceptability of GCAT  
In terms of acceptability of treatment, 69% (N=108) of patients that started GCAT 
completed treatment.  The GCAT treatment refusal rate (offered but did not attend 
GCAT) was 12% (N=19), with 19% (N=49) dropping out during group treatment.  
As shown in table 4, patients that completed GCAT scored significantly higher on 
the self-esteem measure at the start of the group than non-completers (RSES, z=-
3.02, p=0.003).  There were no other significant differences in terms of 
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demographic variables or outcome measure scores between the non-completer 
and completer samples.   
 
insert table 4 here please 
 
Primary Outcomes  
Table 5 presents the pre/post GCAT mean score, change scores, 95% confidence 
intervals, uncontrolled effect sizes and RCI rates for the patients offered GCAT and 
GCAT completer sample.  The effect size for the primary outcome measure (BSI-GSI 
d+= 0.34) suggests that completion of GCAT was associated with a moderate 
improvement in global psychological distress.  The results of the ANOVA indicated 
a main effect of time on the primary outcome (BSI-GSI; F(1.762, 260.79) =9.93, 
p<0.001), but not completer/non-completer status (F(1, 148) =0.037, p=0.85).  
Simple contrasts illustrated that patients offered GCAT experienced statistically 
significant reductions in global distress scores from assessment to the end of GCAT 
(F(1, 148) =14.765, p<0.001), however, significant reductions from assessment to 
start of GCAT (F(1, 148) =5.08, p=0.026) and during GCAT (F(1,148) =6.764, 
p=0.01) also occurred.  Such improvement during wait-time reduces the 
confidence with which change during GCAT can be attributed to treatment.  There 
was, however, a significant interaction between completer status and time (F(1.76, 
260.79) =5.374, p=0.007), with simple contrasts suggesting that completers 
achieved significantly more therapeutic gains on the BSI during GCAT (F(1,148) 
=7.43, p=0.007). 
 
Insert table 5 here please 
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Figure 2 displays RCI rates for the GCAT completer sample on the BSI-GSI 
where scores were available at both start and end of GCAT (N=103).  The dashed 
vertical and horizontal lines represent the clinical cut-off (0.78) at pre/post GCAT 
and each dot represents a GCAT patient. Eleven patients (11%) demonstrated 
reliable and clinically significant change and therefore met the criteria for 
'recoverǯȋ ? ? ?Ȍa reliable improvement in 
BSI-GSI outcomes.  Seven patients (7%) met the criteria for reliable deterioration, 
one of whom demonstrated a reliable and clinically significant deterioration 
during GCAT.  Figure 2 shows that a 'stasis' outcome was the most common 
individual outcome following GCAT on the BSI-GSI.         
 
insert figure 2 here please 
 
Table 6 presents the benchmarking evidence from matched group 
treatment outcome studies of female survivors of CSA and Figure 3 presents a 
forest plot of associated uncontrolled effect sizes with the 95% confidence 
intervals. These are weighted according to sample size.  The effect sizes for the 
group therapy studies ranged between 0.34-1.02 and had a standard deviation of 
0.26.  Where confidence intervals for group therapies overlap the vertical full line, 
it demonstrates that at the given level of confidence, the effect size did not differ ǮǯȋȌǤConfidence intervals 
in three studies indicate detrimental therapeutic effects. However, the small 
sample sizes (all N  ?46) of these studies resulted in much broader confidence 
intervals (Lueger & Barkham, 2010).  The weighted mean group therapy effect size 
was 0.56 (the vertical dashed line) with a 95% confidence interval from 0.39 to 
0.73 (k=7, N=297).  GCAT had a moderate within-study uncontrolled effect size of 
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0.34, which contributed 37.83% to the overall between-studies effect size.  There 
was no significant heterogeneity between studies (p=0.08) suggesting that it is 
appropriate to draw the tentative comparative conclusions.   
 
insert table 6 and figure 3 here please 
 
Secondary Outcomes 
Table 4 also contains the pre/post GCAT secondary outcome measure 
means, change scores, 95% confidence intervals, uncontrolled effect sizes and RCI 
rates for the offered GCAT (d+ range 0.23-0.38) and GCAT completer samples (d+ 
range 0.35-0.58).  Effect sizes suggest that completion of GCAT was associated with 
generally moderate to substantial improvements across the secondary outcome 
measures (excluding self-esteem).  
In terms of interpersonal functioning scores, no statistically significant 
improvement was observed during wait-time (F(1,145) =1.55, p=0.22), but a 
significant difference was observed during GCAT (F(1,145) =5.751, p=0.02).  It is 
possible therefore to tentatively infer that interpersonal change achieved was due 
to the intervention. Completer status and time interacted (F(1.67, 242.07) =4.219, 
p=0.02) to again suggest that completers achieved more change during GCAT 
(F(1,145) =5.41, p=0.021). 
Main effects over time were observed for depression (HADS-D; F(1.425, 
212.35) =17.721, p <0.001) and anxiety scores (HADS-A; F(1.62, 243.017) =9.39, 
p<0.001).  Simple contrasts revealed both an overall improvement in depression 
scores during baseline (F(1,149) =6.86, p=0.01) and scores during GCAT (F(1,149) 
=14.103, p<0.001).  Anxiety scores appeared more stable during baseline (F(1,150) 
=1.284, p=0.259), with improvements observed in anxiety scores during GCAT 
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(F(1,150) =10.614, p=0.001). ǯȋ	ȋ ?ǡ ? ? ?Ȍ ? ? ?Ǥ ? ?ǡp=0.001) 
and anxiety scores (F(1,150) =8.79, p=0.004) reduced more than non-completers 
during GCAT.  No significant interaction was observed during baseline for either 
depression (F(1,149) =0.439, p=0.51) or anxiety scores (F(1,150) =0.34, p=0.56).   
Overall, for patients offered GCAT, there was an increase in self-esteem 
scores whilst waiting for treatment (F(1,145) =20.85, p<0.001) and a difference 
was also observed during GCAT (F(1,145) =12.138, p=0.001). The difference in 
self-esteem scores between assessment and end of GCAT were not significant (F(1, 
145) = 3.667, p=0.057).  There was an interaction between time and completers 
status (F(1.80, 261.54) =6.20, p=0.003), with a significant difference between 
completers/non-completers' self-esteem scores at assessment, with completers 
then achieving significantly greater gains (F(1,145) =8.35, p=0.004).  There was 
also a significant difference between completers/non-completers' self-esteem 
outcomes during GCAT (F(1,145) =13.26, p<0.001).  However, this was not in the 
expected direction. D
ǯ-esteem scores significantly 
deteriorated. No main effect for completer status was observed (F(1,145)=1.647, 
p=0.201). 
In terms of general well-being (GHQ scores; N=150), there was a significant 
main effect of time (F(1.736, 256.879) =11.09, p<0.001).  Simple contrasts 
revealed no significant change in well-being scores during baseline (F(1,148) 
=3.268, p=0.073), with a significant overall improvement during GCAT (F(1,148) 
=8.817, p=0.003).  No main effect of completer status was found (F(1,148) =0.052, 
p=0.821), but completer status and time significantly interacted (F(1.74, 256.88) 
=6.04, p=0.004).  No significant interaction was observed during baseline (F(1, 
148) =0.001, p=0.978), but based on their GHQ scores completers achieved 
significantly more gains in terms of their general mental health during GCAT 
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(F(1,148)= 7.831, p = 0.006).  Pre-post individual change rates (i.e. RCI analysis) 
were highest on the depression (HADS-D) and general mental health (GHQ) 
outcome measures.  The reliable and clinically significant improvement rate was 
16% (N=16) for depression and 16% (N=16) for general mental health.  In terms of 
just a reliable improvement, then 23 patients (22%) achieved a reliable reduction 
in anxiety scores, of whom almost half (10%) also achieved a clinically significant 
change.  Despite the overall statistically significant deterioration in mean self-
esteem scores during GCAT, 14% (N=14) of those completing treatment achieved 
reliable and clinically significant improvement and 11% (N=11) achieved a reliable 
improvement.  Although mean IIP-32 scores significantly improved during GCAT, 
no single patient met the criteria for a reliable and clinically significant 
improvement in their interpersonal functioning.   Reliable deterioration rates 
ranged from 2% to 7%, with five patients demonstrating reliable and clinically 
significant deterioration on the GHQ-28.  McNemar tests illustrated that a 
significantly greater proportion of completers achieved reliable improvements 
during GCAT compared to wait-time: BSI-GSI (p=0.004); IIP-32 (p=0.001); RSES 
(p=0.001); HAD-A (p<0.001); HAD-D (p<0.001) and GHQ (p<0.001).   
 
Discussion 
This study represents the first attempt to evaluate GCAT for highly 
distressed female survivors of CSA in routine clinical practice.  The results 
generally suggest that GCAT can be an effective approach for those patients 
completing therapy, as an adjunct to care provided in secondary mental health 
setting. Completing treatment was found to be beneficial, which is consistent with 
previous findings (e.g. Cahill et al., 2003). One in five women achieved a reliable 
improvement during GCAT on the primary outcome measure.  It is worth noting 
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however that 7% of GCAT patients also experienced a reliable deterioration in 
their global psychological distress.  A relatively small (but nontrivial) minority of 
patients can deteriorate during psychological treatment, with estimates ranging 
from 3-10% (Mohr, 1995).  The low rates of change found may have been due to 
the relative brevity of GCAT ǯ
difficulties. Previous research has suggested that patients with severe and 
enduring interpersonal difficulties require lengthy group treatments, which far 
exceed the 24-session format evaluated in the current study (Budman & Gurman, 
1988; Lorentzen & Høglend, 2008).  
GCAT was found to be a (statistically) moderately effective intervention 
with an effect size of 0.34 on the primary outcome measure. However, statistical 
improvements in global psychological distress were also demonstrated from 
assessment to start of group therapy.  This improvement does undermine 
confidence in attributing change solely to GCAT attendance. Benchmarking the 
GCAT effect size found it to be lower than for other group therapies.  This may 
have been due to the high pre-treatment distress apparent in the current sample; 
the GCAT effect size was comparable to analytic group therapy for CSA survivors 
with similarly high levels of pre-treatment distress (Lau & Kristensen, 2007). 
Differences may also be due to factors such as variance in group climate or specific 
patient/therapist variables (Ogrodniczuuk, Piper & Joyce, 2006) not measured in 
this study.  
In terms of acceptability of treatment, 69% of patients offered GCAT 
completed treatment, with 12% failing to attend any sessions and 19% dropping 
out during treatment.  This represents a relatively low dropout rate compared to 
other group therapy approaches used with females CSA survivors.  For example, 
Fisher et al., (1993) reported a drop out rate of 41% from group psychodynamic 
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psychotherapy, Lau & Kristensen (2007) 38% from systemic group therapy and 
Talbot et al, (1999)  ? ? ?ǮǯǤRyle et al., (2014) noted 
that a key feature of CAT is rapid reformulation and speculated that this may be a 
key factor contributing to the low dropout rates observed across CAT outcome 
studies.  Acceptability of treatment is particularly pertinent for survivors who 
often endure on-going marginalisation and adversity, which can then markedly 
limit their capacity to effectively engage with services (Fisher, et al, 1993). 
On the secondary outcome measures, interpersonal functioning, anxiety 
and wellbeing scores were stable during wait-time and improved during GCAT, 
indexing the impact of group treatment on these factors.  Similar to the outcome 
pattern on the primary outcome measure, there was a trend for improvements in 
depression and self-esteem scores prior to GCAT during wait-time following initial 
screening.  Previous research has highlighted the therapeutic impact of hope-
inducing, collaborative assessment (Finn & Tonsager, 1997).  Depression scores 
continued to improve during GCAT, however, the self esteem scores of completers 
did deteriorate during group treatment.  Previous CAT research with CSA 
survivors has also evidenced deterioration of self-esteem scores during group 
treatment (Clarke & Pearson, 2000).   
As this study involved the retrospective analysis of a practice-based dataset 
there are many aspects of internal validity that are open to criticism, such as lack 
of methodological control and also threats to the actual quality of the data (i.e. 
missing outcome data, Barkham, Stiles, Lambert & Mellor-Clark, 2010).   The 
results therefore need to be interpreted with due caution.  An obvious limitation 
was the lack of a contemporaneous comparison or control group to compare the 
GCAT outcomes against.  Although the study attempted to address this by use of a 
within group waitlist comparison, this was not a completely adequate control as it 
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was not possible to account for the differing lengths of time that patients waited 
for GCAT.  There was also no systematic recording of concurrent interventions 
from community mental health teams.  Therefore, it is impossible to say with any 
level of certainty that the improvement (or deterioration) observed during GCAT 
could be solely attributed to group treatment.  All measures were fairly generic 
measures of mental health and the study could have been improved by the 
inclusion of a CSA specific outcome measure (e.g. The Trauma-Related Guilt 
Inventory; Kubany et al. 1996) or CSA-related treatment targets, such as reduced 
incidents of self-harm and/or inappropriate sexual boundaries.  No measure of 
therapist competence/model fidelity was used and therefore poor adherence or 
therapist drift (Waller, 2009) may well have occurred.   Furthermore, although this 
study explored group CAT outcomes, it did not take into account intragroup effects 
that may have influenced findings, for example, correlations between group 
members' scores (Baldwin, Murray & Shadish, 2005). Whilst the study usefully 
benchmarked GCAT outcomes, the range of available benchmarks was limited and 
so only tentative comparative conclusions could be drawn.  The lack of follow-up 
data represents a major study weakness.   
This study does suggest some potential new avenues for future research. A 
pragmatic trial of group CAT for survivors is indicated from these preliminary 
findings. Future GCAT studies should report the intraclass correlation as this will 
help to identify the intragroup effects that may be influencing outcome and also 
ensure adequate sample sizes to ensure statistical power (Kenny, 2002).   
Methodologies that enable short and long-term follow-up from groups would index 
the clinical durability GCAT.  Research is needed to determine the optimum GCAT 
treatment duration for survivors with significant interpersonal difficulties.  As 
group delivery of CAT is increasingly popular (Ryle et al., 2014), a measure of 
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group treatment fidelity is needed to mirror the competency measure developed 
for use with individual CAT (CCAT; Bennett & Parry, 2004). Findings were limited 
to female survivors and future studies should prioritise investigating outcomes for 
male survivors; a much neglected clinical and research population ȋǯƬ
Gould, 2010). 
In conclusion, this study suggests encouraging initial evidence that GCAT 
appears an acceptable and moderately effective treatment with highly distressed 
female survivors of CSA.  A small proportion of female survivors achieved ǮǯǡǤClearly, the GCAT 
approach is much in need of further detailed and controlled evaluation. There  
remains an urgent need for researchers and clinicians to coordinate strategies to 
improve the overall quality of psychological care offered to men and women 
struggling with the emotional consequences of being sexually abused as a child. 
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Figure 1; diagram to illustrate flow of patients through the study  
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Table 1; summary of evidence used to calculate reliable and clinically significant change 
 
Measure Norm N Norm 
Mean 
Norm SD Reliability  
co-efficient 
 
Reliable Change  
Index value 
Clinical significance  
cut-off score 
 
Clinical significance  
criterion source 
 
 
BSI-GSI1 252a 
8b 
376c 
1.66 
1.80 
0.44 
0.83 
1.13 
0.47 
0.90* 0.79 0.78 
 
Externally derived  
(Derogatis, 1993) 
 
IIP-322 
 
 
76d 
45e 
 
 
1.47 
0.95 
 
 
0.65 
0.52 
 
 
0.70* 
 
 
0.99 
 
 
1.39 
 
 
 
Jacobson & Truax (1991), criteria 'C' 
RSES3 Not 
available 
Not 
available 
Not 
available 
0.85* 5.86 25.22 Jacobson & Truax (1991), criteria 'A' 
HADS4 
Anxiety 
Depression 
 
 
1792f 
 
1792f 
 
 
3.68 
 
6.14 
 
 
3.07 
 
3.76 
 
 
0.89** 
 
0.92** 
 
 
4.27 
 
3.66 
 
 
11 
 
11 
 
 
Externally derived 
(Crawford, Henry, Crombie & Taylor, 
2001) 
 
 
GHQ-285 1670g 5.68 6.15 0.90* 7.67 7 Externally derived  
(Goldberg et al., 1997) 
 
 
1Brief Symptom Inventory Ȃ Global Severity Index 2Inventory of Interpersonal Problems-32 3Rosenberg Self-Esteem Scale 4Hospital Anxiety and Depression Scale 5General 
Health Questionnaire 
a Ryan, 2007; clinical sample bClarke & Llewelyn, 1994; clinical sample cFrancis, Rajan, & Turner, 1990; non-clinical sample dBarkham, Hardy, & Startup, 1996; clinical 
sample eBarkham, Hardy, & Startup, 1996; non-clinical sample fCrawford, Henry, Crombie, & Taylor, 2001 non-clinical sample gWillmott, Boardman, Henshaw, & Jones, 
2004; non-clinical sample 
*Published test-retest co-efficient **No published test-retest reliability co-efficients, therefore published Cronbach D are used to derive the RCI. 
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Table 2; demographic characteristics for patients not offered GCAT and offered GCAT  
 
Characteristic Patients referred to the 
service and not offered 
GCAT (n=221) 
Patients referred to the 
service and offered GCAT  
(n=157) 
Mann Whitney U Test / 
Chi-squared test 
 
Age (years) 34.51 ± 11.74 
(17-87 years) 
34.65 ± 10.67 
(18-64 years) 
Z=-0.35, p=0.72 
Ethnicity 
White 
Non-White 
Unknown 
 
164 (74%) 
8 (4%) 
49 (22%) 
 
138 (88%) 
7 (4%) 
12 (8%) 
 ɖ2 (1, N=317) =0.005, p=0.94 
Relationship status 
In a relationship 
Not in a relationship 
Unknown 
 
 77(35%) 
100 (45%) 
44 (20%) 
 
86 (55%) 
62 (39%) 
9 (6%) 
 ɖ2 (1, N=325) =6.88, p=0.009* 
Employment status 
Paid employment 
Unemployed 
Other (e.g. studying, retired) 
Unknown 
 
39 (18%) 
84 (38%) 
23 (10%) 
75 (34%) 
 
44 (28%) 
66 (42%) 
15 (10%) 
32 (20%) 
 ɖ2 (2, N=271) =2.53, p=0.28 
 
 
*p < .01 significant 
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Table 3; outcome scores at assessment for patients who returned assessment outcome booklets and were not offered GCAT and patients who 
returned assessment outcome booklets and were offered GCAT  
 
Measure Patients who returned 
baseline measures and not 
offered GCAT (n=81) 
Patients who returned 
baseline measures and 
offered GCAT 
(n=157) 
Mann Whitney U test 
 
 N Mean SD N Mean SD  
  
BSI-GSI1 73 
 
2.21 0.90 154 
 
2.28 0.87 Z=-0.98, p=0.43 
IIP-322 72 1.99 0.65 148 1.97 0.62 Z=-0.39, p=0.69 
RSES3 71 
 
16.57 5.47 149 
 
15.30 4.96 Z=-5.35, p<0.001* 
HADS4 
Anxiety 
Depression 
 
76 
76 
 
14.06 
11.21 
 
4.45 
3.91 
 
153 
153 
 
14.01 
11.29 
 
4.09 
4.64 
 
Z=-0.04, p=0.97 
Z=-0.54, p=0.59 
GHQ-285 70 16.27 8.10 152 16.58 8.21 Z=-0.94, p=0.35 
 
Note. n ranged due to missing data on some measures  
1Brief Symptom Inventory Ȃ Global Severity Index 2Inventory of Interpersonal Problems-32 3Rosenberg Self-Esteem Scale 4Hospital Anxiety and Depression Scale 5General 
Health Questionnaire 
*p < .001 significant 
  
  
4
1
 
Table 4; demographic characteristics, presenting problems and pre-GCAT scores for the non-completer and completer samples  
 
 Non-completers (N=49) Completers (N=108) Mann Whitney U test / 
Chi Squared test / 
Independent samples t test 
 
Age (years) 33.01 ±11.23 
(18-64 years) 
 
35.39 ±10.36 
(19-60 years) 
 
z= -1.48, p=0.14 
Ethnicity 
White 
Non-White 
Unknown 
 
44 (90%) 
2 (4%) 
3 (6%) 
 
94 (87%) 
5 (5%) 
9 (8%) 
ɖ2 (1, N=145) =0.034, p=0.85 
Relationship status 
In a relationship 
Not in a relationship 
Unknown 
 
28 (57%) 
20 (41%) 
1 (2%) 
 
58 (54%) 
42 (39%) 
8 (7%) 
 
ɖ2 (1, N=148) =0.001, p=0.97 
Employment status 
Paid employment 
Unemployed 
Other (e.g. studying, retired) 
Unknown 
 
14 (29%) 
21 (43%) 
6 (12%) 
8 (16%) 
 
30 (38%) 
45 (42%) 
9 (8%) 
42 (22%) 
 
ɖ2 (2, N=125) =0.401, p=0.82 
 
Internalising difficulties 
Recorded at assessment 
Not recorded at assessment 
 
 
47 (96%) 
2 (4%) 
 
100 (93%) 
8 (7%) 
 
x2 (1, N=157)=0.625, p=0.73 
Externalising difficulties 
Recorded at assessment 
Not recorded at assessment 
 
 
14 (29%) 
35 (71%) 
 
31 (29%) 
77 (71%) 
 
x2 (1, N=157)<0.001, p=1.00 
Substance use 
Recorded at assessment 
Not recorded at assessment 
 
 
6 (12%) 
43 (88%) 
 
12 (11%) 
96 (89%) 
 
x2 (1, N=157)=0.043, p=0.79 
Self-harm behaviours 
Recorded at assessment 
 
17 (35%) 
 
31 (29%) 
 
x2 (1, N=157)=0.57, p=0.46 
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Not recorded at assessment 
 
32 (63%) 77 (71%) 
Sexual difficulties 
Recorded at assessment 
Not recorded at assessment 
 
 
3 (6%) 
46 (94%) 
 
13 (12%) 
95 (88%) 
 
x2 (1, N=157)=1.288, p=0.39 
Re-victimisation experiences 
Recorded at assessment 
Not recorded at assessment 
 
 
9 (18%) 
40 (82%) 
 
10 (9%) 
98 (91%) 
 
x2 (1, N=157)=2.63, p=0.12 
 
 N Mean SD N Mean SD   
Measure  
BSI-GSI1 47 2.11 0.89 103 2.18  0.92 
 
t(148)=0.282, p=0.78 
IIP-322 46 
 
1.96 
 
0.70 101 
 
1.91  0.62 
 
t(145)=-0.52, p=0.60 
RSES3 45 
 
16.36 5.48 102 19.42  5.21 z=-3.02, p=0.003* 
HADS4 
Anxiety 
Depression 
 
 
48 
48 
 
 
13.33 
10.08 
 
 
4.85 
4.76 
 
 
104 
103 
 
14.03 
11.18 
 
 
4.10 
4.61 
 
 
z=-0.611, p=0.54 
t(149)=1.345, p=0.18 
GHQ-285 49 14.48 8.20 101 16.11 9.05 z=-1.314, p=0.19 
 
Note. n ranged due to missing data on some measures 
1Brief Symptom Inventory Ȃ Global Severity Index 2Inventory of Interpersonal Problems-32 3Rosenberg Self-Esteem Scale 4Hospital Anxiety and Depression Scale 5General 
Health Questionnaire 
*p < .01 
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Table 5; Pre/Post GCAT outcomes, effect sizes, and reliable and clinically significant change for the assigned-to-GCAT and completer samples 
 
 Assigned-to-GCAT sample (N=157) Completer sample (N=108) 
   
 
 
Measure 
N pre- 
GCAT 
mean 
(sd) 
post- 
GCAT 
mean 
(sd) 
pre-post 
change 
score 
 
95% 
C. I. 
 
effect 
size 
N pre- 
GCAT 
mean 
(sd) 
post- 
GCAT 
mean  
(sd) 
pre-post 
change 
score 
 
95% 
C. I. 
 
effect 
size 
RCSI1 RI2 RD3 RCSD4 
 
BSI-GSI 154 
 
2.10 
(0.90) 
1.93 
(1.00) 
0.17 0.00-
0.46 
0.19 103 2.18 
(0.92) 
1.87 
(1.08) 
0.31 0.06-
0.61 
0.34 11 
(11%) 
10 
(10%) 
6 
(6%) 
1 
(1%) 
 
IIP-32 148 1.93 
(0.65) 
1.78 
(0.69) 
0.15 0.00-
0.46 
0.23 101 
 
1.91 
(0.62) 
1.69 
(0.68) 
0.22 0.07-
0.63 
0.35 0 11 
(11%) 
1 
(1%) 
1 
(1%) 
RSES 149 
 
18.49 
(5.47) 
16.42 
(5.76) 
2.07 0.15-
0.61 
0.38 102 19.42 
(5.21) 
16.41 
(5.91) 
3.01 0.29-
0.86 
0.58 14 
(14%) 
11 
(11%) 
3 
(3%) 
0 
HAD-A 153 
 
13.81 
(4.35) 
12.53 
(4.60) 
1.28 0.06-
0.51 
0.29  
104 
 
14.03 
(4.10) 
12.26 
(4.47) 
1.77 0.15-
0.71 
0.43 10 
(10%) 
13 
(13%) 
2 
(2%) 
2 
(2%) 
HAD-D 152 10.83 
(4.67) 
9.39 
(5.18) 
1.44 0.08-
0.54 
0.31 103 11.18 
(4.61) 
9.13 
(5.37) 
2.05 0.17-
0.72 
0.44 16 
(16%) 
3 
(3%) 
2 
(2%) 
0 
GHQ-28 154 
 
15.57 
(8.78) 
12.75 
(9.29) 
2.82 0.09-
0.55 
0.32 101 16.11 
(9.05) 
11.97 
(9.72) 
4.14 0.17-
0.74 
0.46 16 
(16%) 
7 
(7%) 
2 
(2%) 
5 
(5%) 
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Note. n ranged due to missing data on some measures  
1Reliable and Clinically Significant Improvement 2Reliable Improvement 3Reliable Deterioration 4Reliable and Clinically Significant Deterioration 
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Figure 2; scatterplot of individual BSI outcomes for GCAT completers completing pre/post outcomes (n=103) 
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Figure 3; forest plot of group interventions for CSA survivors  
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Table 6; pre- and post-therapy scores and effect sizes for group interventions for CSA survivors 
 
Author(s) 
 
Group Treatment 
(Duration); Sample Size 
Setting Pre-therapy 
M (SD) 
Post-therapy 
M (SD) 
Effect size 
 
Lubin (1998)ș Trauma focused CBT 
(16 sessions); n=29 
Community 113.31 (78.14) 86.69 (75.32) 0.34 
Saxe and Johnson (1999)Ș Ǯǯ 
(20 sessions); n=32 
Clinical outpatient 1.62 (0.58) 1.03 (0.65) 1.02 
Talbot (1999)ș Trauma recovery therapy 
(10 sessions); n=20 
Inpatient 57.45  (7.79) 49.90 (9.41) 0.97 
Lundqvist and Ojehagen (2001)ș Long-term psychodynamic therapy 
(2 years); n=22 
Clinical outpatient 1.38 (0.80) 0.96 (0.80) 0.53 
      
Lau and Kristensen (2007)ș Analytic therapya 
(46 sessions); n=40 
 
Systemic therapyb 
(17 sessions); n=46 
Clinical outpatient 1.95 (0.75) 
 
 
1.61 (0.61) 
1.63 (0.77) 
 
 
0.99 (0.69) 
0.43 
 
 
1.02 
 
 
Current sampleȘ Cognitive Analytic Therapy 
(24 sessions); n=108 
Clinical outptient 2.18 (0.92) 1.87 (1.08) 0.34 
 șSCL-90, ȘBSI
  48 
 
 
 
 
 
 
 
 
 
 
 
 
